Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
Biochimica Et Biophysica Acta|May 6, 2003
Cellular localisation and nuclear export of the human bZIP transcription factor TCF11Cathrine Husberg, Paula Murphy, Elisa Bjørgo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1994
Serum antibodies from MS patients do not recognize HTLV-I, HIV-1, HIV-2 and SIVK A Brokstad, K H Kalland, M Page, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 31, 2023
Persistent Postural-Perceptual Dizziness (PPPD) and quality of life: a cross-sectional studyMalin Herwander Steensnaes, Mari Kalland Knapstad, Frederik Kragerud Goplen, et al.
Disability and Rehabilitation|January 3, 2022
The Dizziness Handicap Inventory and sickness absence: a cross-sectional studyMari Kalland Knapstad, Frederik Kragerud Goplen, Stein Helge Glad Nordahl, et al.
Nordic Journal of Psychiatry|July 1, 2010
Substance abusing mothers in residential treatment with their babies: postnatal psychiatric symptomatology and its association with mother-child relationship and later need for child protection actionsMarjukka Pajulo, Nina Pyykkönen, Mirjam Kalland, et al.
The New Biologist|April 1, 1991
Rex-dependent nucleolar accumulation of HTLV-I mRNAsK H Kalland, E Langhoff, H J Bos, et al.
Blood|March 15, 1997
A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignanciesC Gidlöf, M Dohlsten, P Lando, et al.
Molecular and Cellular Biology|November 1, 1994
The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartmentsK H Kalland, A M Szilvay, K A Brokstad, et al.
Frontiers in Sports and Active Living|July 15, 2022
Differences in Upper-Body Peak Force and Rate of Force Development in Male Intermediate, Advanced, and Elite Sport ClimbersVegard Vereide, Vidar Andersen, Espen Hermans, et al.
International Journal of Molecular Medicine|December 16, 1998
MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinomaD W Newton, M Dohlsten, P A Lando, et al.
Pageof 31